Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semaglutide for Reducing Cardiovascular Events in Patients Undergoing Transcatether Aortic Valve Replacement

NCT07090343 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT07090343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semaglutide for Reducing Cardiovascular Events in Patients Undergoing Transcatether Aortic Valve Replacement
Lead sponsor
Leiden University Medical Center
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
April 1, 2031
Enrollment
826 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, heart failure